Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Berkeley
State: California
Zip:
Country: United States
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics&s; therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2018 | Seed Round | 1 | - |
Endpoint Ventures Endpoint Ventures |
8/2018 | Seed Round | 1 | - |
Y Combinator Y Combinator |
8/2018 | Seed Round | 1 | - |
Endpoint Ventures Endpoint Ventures |
8/2018 | Seed Round | 1 | - |
Y Combinator Y Combinator |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|